(Q36827362)

16 August 2017

1 reference

title

Current concepts of the cellular and molecular pathophysiology of multiple sclerosis (English)

1 reference

16 August 2017

0 references

Jeffrey I Greenstein

1

1 reference

16 August 2017

publication date

1 August 2007

1 reference

16 August 2017

number of pages

18

1 reference

Developmental Neurobiology

inferred from page(s)

published in

1 reference

16 August 2017

volume

67

1 reference

16 August 2017

issue

9

1 reference

16 August 2017

page(s)

1248-1265

1 reference

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

The 77C->G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Peripheral T-cell tolerance: the contribution of permissive T-cell migration into parenchymal tissues of the neonate

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

T cells responsive to myelin basic protein in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CNS energy metabolism as related to function

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Changes in neurotransmitters in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Axonal protection using flecainide in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Integrin signalling in neutrophils and macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Efficient central nervous system remyelination requires T cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CTLA4Ig: bridging the basic immunology with clinical application

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Mechanisms of immune injury in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Oligodendrocytes in the early course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Prospective study on the relationship between infections and multiple sclerosis exacerbations.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Isolation of myelin basic protein-reactive T-cell lines from normal human blood

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Natural history of multiple sclerosis: a unifying concept

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The risk of relapses in multiple sclerosis during systemic infections

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Remyelination of cytokine- or antibody-demyelinated CNS aggregate cultures is inhibited by macrophage supplementation

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Genetics of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Axonal damage in acute multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Inflammation stimulates remyelination in areas of chronic demyelination.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Why does remyelination fail in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The value of animal models for drug development in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis--the plaque and its pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CD45: a critical regulator of signaling thresholds in immune cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: MHC associations and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Further evidence in support of the hypothesis that one cause of multiple sclerosis is childhood infection

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Calpain inhibitors confer biochemical, but not electrophysiological, protection against anoxia in rat optic nerves.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Expression of CCR7 in multiple sclerosis: implications for CNS immunity

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A central role for central tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The CTLA-4 gene is associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Regulatory T cells in the periphery

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CD4+CD28- costimulation-independent T cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A transcription function for the T cell-specific adapter (TSAd) protein in T cells: critical role of the TSAd Src homology 2 domain

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Interleukin-1beta promotes repair of the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Lymphocyte traffic control by chemokines: follicular B helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Genetic factors in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Molecular mimicry and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Restricted use of VH4 germline segments in an acute multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Influence of infection on exacerbations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: remyelination of nascent lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Immunopathology of secondary-progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Expansion of antigen-specific T cells from cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Secondary progressive multiple sclerosis: current knowledge and future challenges

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: updated risks for relatives

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A new era in the genetic analysis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

CNS axons retain their competence for myelination throughout life.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

From vanilla to 28 flavors: multiple varieties of T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Clinical viral infections and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Transcriptional analysis of targets in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Neurotransmitters in cerebrospinal fluid reflect pathological activity.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

White matter injury mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Unveiling the enigma of the CNS as a B-cell fostering environment

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+regulatory T-cell function and FOXP3 expression

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Na+ channel expression along axons in multiple sclerosis and its models

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

A point mutation in PTPRC is associated with the development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Myelination determines the caliber of dorsal root ganglion neurons in culture

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

T(H)-17: a giant step from T(H)1 and T(H)2

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors

1 reference

https://api.crossref.org/works/10.1002%2FDNEU.20387

7 January 2021

Identifiers

DOI

10.1002/DNEU.20387

1 reference

16 August 2017

1 reference